These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
914 related articles for article (PubMed ID: 12929930)
1. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930 [TBL] [Abstract][Full Text] [Related]
2. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related]
3. SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Yu X; Collin-Osdoby P; Osdoby P Connect Tissue Res; 2003; 44 Suppl 1():79-84. PubMed ID: 12952178 [TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931 [TBL] [Abstract][Full Text] [Related]
5. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775 [TBL] [Abstract][Full Text] [Related]
6. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
7. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Kollet O; Dar A; Shivtiel S; Kalinkovich A; Lapid K; Sztainberg Y; Tesio M; Samstein RM; Goichberg P; Spiegel A; Elson A; Lapidot T Nat Med; 2006 Jun; 12(6):657-64. PubMed ID: 16715089 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Zannettino AC; Farrugia AN; Kortesidis A; Manavis J; To LB; Martin SK; Diamond P; Tamamura H; Lapidot T; Fujii N; Gronthos S Cancer Res; 2005 Mar; 65(5):1700-9. PubMed ID: 15753365 [TBL] [Abstract][Full Text] [Related]
9. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007 [TBL] [Abstract][Full Text] [Related]
10. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
11. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593 [TBL] [Abstract][Full Text] [Related]
12. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014 [TBL] [Abstract][Full Text] [Related]
13. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676 [TBL] [Abstract][Full Text] [Related]
14. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. Petit I; Goichberg P; Spiegel A; Peled A; Brodie C; Seger R; Nagler A; Alon R; Lapidot T J Clin Invest; 2005 Jan; 115(1):168-76. PubMed ID: 15630457 [TBL] [Abstract][Full Text] [Related]
15. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
16. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Tang CH; Tan TW; Fu WM; Yang RS Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907 [TBL] [Abstract][Full Text] [Related]
17. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720 [TBL] [Abstract][Full Text] [Related]